(E)-3-((6-(pyridin-3-yl)imidazo[2,1-b]thiazol-5-yl)methylene)-1,3-dihydro-2H-benzo[g]indol-2-one

ID: ALA4577490

PubChem CID: 155564696

Max Phase: Preclinical

Molecular Formula: C23H14N4OS

Molecular Weight: 394.46

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1Nc2c(ccc3ccccc23)/C1=C\c1c(-c2cccnc2)nc2sccn12

Standard InChI:  InChI=1S/C23H14N4OS/c28-22-18(17-8-7-14-4-1-2-6-16(14)21(17)25-22)12-19-20(15-5-3-9-24-13-15)26-23-27(19)10-11-29-23/h1-13H,(H,25,28)/b18-12+

Standard InChI Key:  JIQDIQZQKYASFP-LDADJPATSA-N

Molfile:  

 
     RDKit          2D

 29 34  0  0  0  0  0  0  0  0999 V2000
    3.8128   -6.5272    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.7511   -5.2051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3047   -5.8886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5415   -5.4224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5774   -6.2389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3651   -6.4571    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8160   -5.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3069   -5.1360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5250   -4.3484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9520   -3.7658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0895   -2.9616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3645   -2.5845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1468   -3.8887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7854   -3.1596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8916   -4.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7008   -4.5640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5253   -3.7870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9758   -3.1141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6182   -2.3897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8105   -2.3369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3616   -3.0145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7216   -3.7362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8214   -2.5981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6283   -5.7401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0671   -6.4308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8828   -6.3952    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2606   -5.6696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8168   -4.9784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0026   -5.0175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  4  2  1  0
  2  3  2  0
  3  1  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  4  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 14  1  0
 13 10  1  0
 13 14  2  0
 14 18  1  0
 17 15  1  0
 15 16  2  0
 16 13  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 17  2  0
 11 23  2  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
  7 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4577490

    ---

Associated Targets(Human)

Leukemia cell (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSCLC (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNS carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell line (83 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovarian carcinoma cell (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Renal cancer cell line (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prostatic carcinoma cell (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Breast carcinoma cell (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

TUBB2B Tubulin (2175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.46Molecular Weight (Monoisotopic): 394.0888AlogP: 5.10#Rotatable Bonds: 2
Polar Surface Area: 59.29Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.79CX Basic pKa: 4.22CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.42Np Likeness Score: -1.33

References

1. Morigi R, Locatelli A, Leoni A, Rambaldi M, Bortolozzi R, Mattiuzzo E, Ronca R, Maccarinelli F, Hamel E, Bai R, Brancale A, Viola G..  (2019)  Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents.,  166  [PMID:30784885] [10.1016/j.ejmech.2019.01.049]

Source